WDR55 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.596800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.248000E-01
Normal-vs-Stage2
7.780800E-01
Normal-vs-Stage3
7.395600E-01
Normal-vs-Stage4
3.631200E-01
Stage1-vs-Stage2
9.603000E-01
Stage1-vs-Stage3
4.784800E-01
Stage1-vs-Stage4
3.730000E-01
Stage2-vs-Stage3
3.673200E-01
Stage2-vs-Stage4
2.610600E-01
Stage3-vs-Stage4
2.816400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.942000E-01
Normal-vs-AfricanAmerican
8.477200E-01
Normal-vs-Asian
6.051000E-01
Caucasian-vs-AfricanAmerican
6.333200E-01
Caucasian-vs-Asian
3.698800E-01
AfricanAmerican-vs-Asian
4.016600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.805200E-01
Normal-vs-Female
9.633400E-01
Male-vs-Female
3.825200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.202000E-01
Normal-vs-Age(41-60Yrs)
5.128200E-01
Normal-vs-Age(61-80Yrs)
9.455600E-01
Normal-vs-Age(81-100Yrs)
8.888600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.848400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.639200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.696400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.617800E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.461440E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.363600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.148000E-01
Normal-vs-Daily Drinker
8.895000E-01
Normal-vs-Weekly Drinker
7.107800E-01
Normal-vs-Occasional Drinker
7.184400E-01
Normal-vs-Social Drinker
6.073600E-01
Non Drinker-vs-Daily Drinker
2.779400E-01
Non Drinker-vs-Weekly Drinker
9.195600E-01
Non Drinker-vs-Occasional Drinker
7.997200E-01
Non Drinker-vs-Social Drinker
7.332800E-01
Daily Drinker-vs-Weekly Drinker
3.608800E-01
Daily Drinker-vs-Occasional Drinker
3.646000E-01
Daily Drinker-vs-Social Drinker
3.051600E-01
Weekly Drinker-vs-Occasional Drinker
8.890800E-01
Weekly Drinker-vs-Social Drinker
8.621600E-01
Occasional Drinker-vs-Social Drinker
9.765800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.079200E-01
Normal-vs-Grade 2
3.337900E-02
Normal-vs-Grade 3
2.770300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.24899999999861E-05
Grade 1-vs-Grade 3
9.69109999999773E-05
Grade 1-vs-Grade 4
3.079200E-01
Grade 2-vs-Grade 3
8.643000E-01
Grade 2-vs-Grade 4
3.337900E-02
Grade 3-vs-Grade 4
2.770300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.300200E-01
Normal-vs-NonDiabetic
8.336200E-01
Diabetic-vs-NonDiabetic
7.352000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.346400E-01
Normal-vs-NoPancreatitis
9.455600E-01
Pancreatitis-vs-NoPancreatitis
1.420760E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.688800E-01
Normal-vs-N1
8.993200E-01
N0-vs-N1
4.385800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.566600E-01
Normal-vs-TP53-NonMutant
9.147600E-01
TP53-Mutant-vs-TP53-NonMutant
2.383700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
